FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics. The first invention refers to a method for producing carrier particles of dry powder composition for inhalation. The above composition contains a fraction of simultaneously micronised particles made of a mix of alpha-lactose monohydrate and magnesium stearate; the above mix has a mass median diameter of less than 20 mcm, and also a fraction of coarse particles of alpha-lactose monohydrate having a mass diameter from 210 to 355 mcm. The above method involves the simultaneous micronisation of particles of alpha-lactose monohydrate and magnesium stearate. That is followed by mixing the above simultaneously micronised particles with the above coarse particles of alpha-lactose monohydrate for at least four hours for spheronising them. Before mixing as specified above, the simultaneously micronised particles are conditioned first at relative humidity 50-70%, temperature 22±2°C over a period of time making 48 hours. What is also described is another method for producing a dry powder composition for inhalation, additionally involving the stage of mixing the above carrier particles with one or more active ingredients.
EFFECT: group of inventions provides decreasing electrostatic charge of the particles.
6 cl, 2 dwg, 6 tbl, 6 ex
Title |
Year |
Author |
Number |
NOVEL CARRIER PARTICLES FOR DRY POWDER INHALATION FORMULATIONS |
2020 |
- Guidi, Tomaso
- Benassi, Andrea
|
RU2823554C1 |
PHARMACEUTICAL DRUG FORMS CONTAINING LOW-DOSAGE ACTIVE COMPONENT FOR DRY POWDER INHALATORS |
2005 |
- Bil'Zi Roberto
- Armanni Andzhela
- Rastelli Roberto
- Kokkoni Daniela
- Muza Rossella
|
RU2371171C2 |
METHOD FOR PRODUCING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATIONS |
2011 |
- Musa Rossella
- Cocconi Daniela
- Chamayou Alain
- Galet Laurence
|
RU2585101C2 |
INHALATION PARTICLES CONTAINING COMBINATION OF ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENTS |
2015 |
- Miozzi Michele
- Rouse Timothy J
- Brambilla Gaetano
|
RU2697867C2 |
PHARMACEUTIC COMPOSITIONS |
2005 |
- Morton Dehvid
- Shott Martin
- Dehjvis Rebekka
|
RU2396943C2 |
NEW CARRIER PARTICLES FOR DRY POWDER COMPOSITIONS FOR INHALATION |
2018 |
- Schiaretti, Francesca
- Buttini, Francesca
- Bettini, Ruggero
- Salomi, Enrico
- Benassi, Andrea
|
RU2745045C1 |
METHOD OF PRODUCING A DRY POWDER COMPOSITION CONTAINING AN ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENT |
2018 |
- Cavecchi, Alessandro
- Merusi, Cristiana
- Pivetti, Fausto
- Schiaretti, Francesca
|
RU2742376C1 |
METHOD OF PRODUCING A DRY POWDER COMPOSITION CONTAINING AN ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENT |
2018 |
- Cavecchi, Alessandro
- Merusi, Cristiana
- Pivetti, Fausto
- Schiaretti, Francesca
|
RU2741427C1 |
PHARMACEUTICAL COMPOSITION FOR INHALATION |
2010 |
- Kamlag Jorik
- Leeune Morgane
- Morton David Aleksander Fodden
|
RU2493833C2 |
DRY POWDER COMPOSITIONS REPRESENTED AS PARTICLES WHICH CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATMENT OF OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY WAYS |
2012 |
- Virz Dzheffri
- Khuang Deniel
- Miller Denfort
- Rao Nagaradzha
- Tarara Tomas E.
|
RU2629333C2 |